{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?page=2&sponsor=Global+Research+Institute", "query": { "sponsor": "Global Research Institute", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 35, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?page=3&sponsor=Global+Research+Institute&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?page=1&sponsor=Global+Research+Institute&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-07T02:07:53.728Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06429332", "title": "International Care Bundle Evaluation in Cerebral Hemorrhage Research", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Intracerebral Hemorrhage", "Intracerebral Haemorrhage", "Intraventricular Hemorrhage", "Stroke", "Cerebrovascular Disease" ], "interventions": [ { "name": "Reversal of Oral anticoagulation within 30 minutes", "type": "OTHER" }, { "name": "Early intensive blood pressure lowering", "type": "OTHER" }, { "name": "Treatment of pyrexia", "type": "OTHER" }, { "name": "Hyperglycemia treatment", "type": "OTHER" }, { "name": "Do-not-resuscitate (DNR) or withdrawal of care", "type": "OTHER" }, { "name": "Referral to Intensive Care", "type": "OTHER" }, { "name": "Referral to Neurosurgery", "type": "OTHER" }, { "name": "Repeat brain imaging", "type": "DIAGNOSTIC_TEST" }, { "name": "Standard care", "type": "OTHER" } ], "intervention_types": [ "OTHER", "DIAGNOSTIC_TEST" ], "sponsor": "Region Skane", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3500, "start_date": "2025-01-07", "completion_date": "2027-07", "has_results": false, "last_update_posted_date": "2026-05-22", "last_synced_at": "2026-10-07T02:07:53.728Z", "location_count": 1, "location_summary": "Oklahoma City, Oklahoma", "locations": [ { "city": "Oklahoma City", "state": "Oklahoma" } ], "official_url": "https://clinicaltrials.gov/study/NCT06429332" }, { "nct_id": "NCT05780541", "title": "PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "COVID-19" ], "interventions": [ { "name": "PF-07304814", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Remdesivir", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 58, "start_date": "2021-09-15", "completion_date": "2023-07-14", "has_results": true, "last_update_posted_date": "2024-02-09", "last_synced_at": "2026-10-07T02:07:53.728Z", "location_count": 31, "location_summary": "Chula Vista, California • Los Angeles, California • Mather, California + 23 more", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Mather", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05780541" }, { "nct_id": "NCT07565142", "title": "Medical Effects of Proximal (In-person) Intercessory (PIP) and Virtual Intercessory Prayer (VIP) on Pain and Anxiety", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pain and Anxiety", "Complementary Therapies" ], "interventions": [ { "name": "Intercessory Prayer", "type": "BEHAVIORAL" }, { "name": "Music Listening", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Maryland, Baltimore", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 180, "start_date": "2024-05-20", "completion_date": "2025-05-19", "has_results": false, "last_update_posted_date": "2026-05-04", "last_synced_at": "2026-10-07T02:07:53.728Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT07565142" }, { "nct_id": "NCT05449418", "title": "Engaging Staff to Improve COVID-19 Vaccination Response at Long-Term Care Facilities", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "COVID-19" ], "interventions": [ { "name": "Full Intervention", "type": "BEHAVIORAL" }, { "name": "Enhanced Usual Care", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "Kaiser Permanente", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 988, "start_date": "2021-08-01", "completion_date": "2026-02-28", "has_results": false, "last_update_posted_date": "2024-09-19", "last_synced_at": "2026-10-07T02:07:53.728Z", "location_count": 2, "location_summary": "Atlanta, Georgia • Seattle, Washington", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT05449418" }, { "nct_id": "NCT04843761", "title": "ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Covid19" ], "interventions": [ { "name": "Remdesivir", "type": "BIOLOGICAL" }, { "name": "Remdesivir Placebo", "type": "DRUG" }, { "name": "Aviptadil", "type": "BIOLOGICAL" }, { "name": "Aviptadil Placebo", "type": "DRUG" }, { "name": "Corticosteroid", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 473, "start_date": "2021-04-20", "completion_date": "2022-11-20", "has_results": true, "last_update_posted_date": "2025-10-24", "last_synced_at": "2026-10-07T02:07:53.728Z", "location_count": 40, "location_summary": "Tucson, Arizona • Fresno, California • Loma Linda, California + 28 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Fresno", "state": "California" }, { "city": "Loma Linda", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04843761" }, { "nct_id": "NCT02726607", "title": "Adapting the HITSystem to Support Prevention of Mother-to-child HIV Transmission", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV" ], "interventions": [ { "name": "HIV Infant Tracking System (HITSystem) 2.0", "type": "BEHAVIORAL" }, { "name": "Standard of PMTCT care", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Kansas Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 157, "start_date": "2015-08-15", "completion_date": "2020-03-20", "has_results": false, "last_update_posted_date": "2020-04-01", "last_synced_at": "2026-10-07T02:07:53.728Z", "location_count": 1, "location_summary": "Kansas City, Kansas", "locations": [ { "city": "Kansas City", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02726607" }, { "nct_id": "NCT05306743", "title": "PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "CONQUEST Quality Improvement Program", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Observational and Pragmatic Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 126, "start_date": "2022-09-23", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2023-10-12", "last_synced_at": "2026-10-07T02:07:53.728Z", "location_count": 3, "location_summary": "Denver, Colorado • New York, New York • Cleveland, Ohio", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "New York", "state": "New York" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05306743" }, { "nct_id": "NCT06782347", "title": "Activating SilverSneakers Benefits for Seniors With Osteoarthritis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Osteoarthritis", "Physical Inactivity" ], "interventions": [ { "name": "Proactive Care", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Milton S. Hershey Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 1454, "start_date": "2026-01-21", "completion_date": "2028-07", "has_results": false, "last_update_posted_date": "2026-02-10", "last_synced_at": "2026-10-07T02:07:53.728Z", "location_count": 1, "location_summary": "Hershey, Pennsylvania", "locations": [ { "city": "Hershey", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06782347" }, { "nct_id": "NCT05780437", "title": "AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "COVID-19" ], "interventions": [ { "name": "AZD7442", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" }, { "name": "Remdesivir", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1455, "start_date": "2021-02-10", "completion_date": "2023-06-09", "has_results": true, "last_update_posted_date": "2025-02-04", "last_synced_at": "2026-10-07T02:07:53.728Z", "location_count": 88, "location_summary": "Tucson, Arizona • Chula Vista, California • Fresno, California + 59 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Chula Vista", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "La Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05780437" }, { "nct_id": "NCT04501978", "title": "ACTIV-3: Therapeutics for Inpatients With COVID-19", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Covid19" ], "interventions": [ { "name": "LY3819253", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Remdesivir", "type": "BIOLOGICAL" }, { "name": "VIR-7831", "type": "BIOLOGICAL" }, { "name": "BRII-196/BRII-198", "type": "BIOLOGICAL" }, { "name": "AZD7442", "type": "BIOLOGICAL" }, { "name": "MP0420", "type": "DRUG" }, { "name": "PF-07304814", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2753, "start_date": "2020-08-04", "completion_date": "2023-07-14", "has_results": false, "last_update_posted_date": "2023-08-25", "last_synced_at": "2026-10-07T02:07:53.728Z", "location_count": 98, "location_summary": "Tucson, Arizona • Chula Vista, California • Fresno, California + 64 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Chula Vista", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "La Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04501978" } ] }